NASDAQ:VIVE - Viveve Medical Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $2.56 +0.06 (+2.40 %) (As of 07/22/2018 04:00 PM ET)Previous Close$2.56Today's Range$2.4850 - $2.6052-Week Range$1.60 - $7.33Volume153,971 shsAverage Volume325,948 shsMarket Capitalization$80.05 millionP/E Ratio-1.21Dividend YieldN/ABeta-0.56 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories. It markets its products through sales employees and distributors in the United States, the Asia Pacific, Europe, the Middle East, Latin America, and Canada. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado. Receive VIVE News and Ratings via Email Sign-up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical SymbolNASDAQ:VIVE CUSIPN/A Webwww.viveve.com Phone720-696-8100 Debt Debt-to-Equity Ratio1.55 Current Ratio6.47 Quick Ratio6.00 Price-To-Earnings Trailing P/E Ratio-1.21 Forward P/E Ratio-1.63 P/E GrowthN/A Sales & Book Value Annual Sales$15.29 million Price / Sales5.24 Cash FlowN/A Price / CashN/A Book Value($0.13) per share Price / Book-19.69 Profitability EPS (Most Recent Fiscal Year)($2.11) Net Income$-36,950,000.00 Net Margins-269.24% Return on Equity-437.98% Return on Assets-103.63% Miscellaneous Employees103 Outstanding Shares31,270,000Market Cap$80.05 Viveve Medical (NASDAQ:VIVE) Frequently Asked Questions What is Viveve Medical's stock symbol? Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE." How were Viveve Medical's earnings last quarter? Viveve Medical Inc (NASDAQ:VIVE) announced its quarterly earnings data on Thursday, May, 10th. The company reported ($0.49) EPS for the quarter, missing the Zacks' consensus estimate of ($0.44) by $0.05. The business earned $3.70 million during the quarter, compared to analysts' expectations of $4.68 million. Viveve Medical had a negative net margin of 269.24% and a negative return on equity of 437.98%. View Viveve Medical's Earnings History. What price target have analysts set for VIVE? 7 equities research analysts have issued 12-month target prices for Viveve Medical's shares. Their predictions range from $6.00 to $11.00. On average, they expect Viveve Medical's stock price to reach $9.20 in the next year. This suggests a possible upside of 259.4% from the stock's current price. View Analyst Ratings for Viveve Medical. What is the consensus analysts' recommendation for Viveve Medical? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viveve Medical in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." What are Wall Street analysts saying about Viveve Medical stock? Here are some recent quotes from research analysts about Viveve Medical stock: 1. Mizuho analysts commented, "We expect the trends in utilization and pricing to continue in 2018. FDA Approval of IDE to Conduct VIVEVE2 Clinical Trial. The FDA approved Viveve’s IDE to conduct a sexual function study in the U.S. The study is expected to start in 2Q18 and will include approximately 250 patients across 25 clinical sites in the U.S. and Canada. The primary endpoint will measure the mean change from baseline in the total FSFI (Female Sexual Function Index) at 12 months. Data from the study is expected in 2H19. Cash Position and Upcoming Catalysts. Viveve’s current cash position stands at approximately $55.7 mil following a recent $35.0 mil equity offering in February." (3/20/2018) 2. Maxim Group analysts commented, "4Q17 revenue of $5.1M, up 108% y/y, was inline with the preannouncement." (3/16/2018) Who are some of Viveve Medical's key competitors? Some companies that are related to Viveve Medical include BioLife Solutions (BLFS), Rockwell Medical (RMTI), Vision Sciences (CGNT), Helius Medical Technologies (HSDT), Fonar (FONR), Second Sight Medical Products (EYES), Zynex Inc. common stock (ZYXI), Edap Tms (EDAP), Semler Scientific (SMLR), BioSig Technologies (BSGM), IRIDEX (IRIX), Soleno Therapeutics (SLNO), Stereotaxis (STXS), Digirad (DRAD) and Dynatronics (DYNT). Who are Viveve Medical's key executives? Viveve Medical's management team includes the folowing people: Mr. Scott C. Durbin, CEO, Sec. & Director (Age 49)Mr. James Gregory Atkinson, Chief Bus. Officer & Pres (Age 60)Ms. Deborah A. Jorn, Sr. Advisor to the CEO & Director (Age 60)Ms. Patricia K. Scheller, Consultant & Director (Age 58)Mr. Jim B. Robbins, VP of Fin. & Admin. and Principal Accounting Officer (Age 54) When did Viveve Medical IPO? (VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group acted as the underwriters for the IPO and Maxim Group was co-manager. Has Viveve Medical been receiving favorable news coverage? News headlines about VIVE stock have trended somewhat negative on Sunday, Accern reports. The research group ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Viveve Medical earned a coverage optimism score of -0.04 on Accern's scale. They also assigned news stories about the company an impact score of 43.63 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days. How do I buy shares of Viveve Medical? Shares of VIVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Viveve Medical's stock price today? One share of VIVE stock can currently be purchased for approximately $2.56. How big of a company is Viveve Medical? Viveve Medical has a market capitalization of $80.05 million and generates $15.29 million in revenue each year. The company earns $-36,950,000.00 in net income (profit) each year or ($2.11) on an earnings per share basis. Viveve Medical employs 103 workers across the globe. How can I contact Viveve Medical? Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-696-8100 or via email at [email protected] MarketBeat Community Rating for Viveve Medical (NASDAQ VIVE)Community Ranking: 3.3 out of 5 ( )Outperform Votes: 154 (Vote Outperform)Underperform Votes: 80 (Vote Underperform)Total Votes: 234MarketBeat's community ratings are surveys of what our community members think about Viveve Medical and other stocks. Vote "Outperform" if you believe VIVE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VIVE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/22/2018 by MarketBeat.com StaffFeatured Article: How do investors use RSI to grade stocks?